Neurology News

Increased mortality in older adults with Alzheimer’s disease and related dementias, especially in underrepresented and vulnerable populations, was closely linked to the COVID-19 pandemic, according to a study published in JAMA Neurology.

Quanterix Corp. has announced a collaboration with Eli Lilly and Co. to advance the diagnosis, monitoring and treatment of Alzheimer’s disease, according to a press release.

WEST PALM BEACH, Florida — BMI was significantly associated with functional disability in patients with MS, as were additional variables related to BMI, according to a study presented at ACTRIMS Forum.

The COVID-19 pandemic disrupted progress toward gender equity in medicine that may resonate for years to come, according to experts.

The FDA has given breakthrough device designation to the SOBA-AD assay, which may detect Alzheimer’s disease before symptoms arise, according to a press release.

WEST PALM BEACH, Florida — Genetically predicted levels of 25-hydroxyvitamin D were generally not associated with adverse disease outcomes in MS patients of European ancestry, according to a study presented at ACTRIMS Forum.

In a noninferiority randomized trial, the antidepressants amitriptyline and venlafaxine significantly reduced the number of migraine attacks per month, according to researchers.

In a company release, Roche announced a collaboration on a new phase 3 Alzheimer’s disease prevention trial, which will test an investigational subcutaneous anti-amyloid antibody.

WEST PALM BEACH, Florida — The National Health and Nutrition Examination Survey Biological Age Index is a reliable predictor of multiple MS disability outcomes and progressive phenotypes, according to a study presented at ACTRIMS Forum.

WEST PALM BEACH, Florida — Physical activity levels and sleep correlated with psychological outcomes in MS, according to data presented at the ACTRIMS Forum.